This week, Peter Simons covers three studies about financial ties to the pharmaceutical industry in editorial and commentary writers in medical journals. These conflicts of interest create biased research literature that helps pharma push potentially harmful and less effective drugs.  

• Conflicts of Interest Linked to“Unduly Favorable” Editorials
• Conflicts of Interest in Medical Commentaries Undermine Credibility of Major Journals
• How Pharma Pushes New, Less Effective Drugs on the Market